Michael Fossel Michael is President of Telocyte

January 8, 2020

Can we cure Alzheimer’s?

You might be intrigued by an invited paper this week in Alzheimer’s & Dementia, which the editors feel “will change the field”. The paper explains how Alzheimer’s works, why prior trials failed, and offers a novel point of intervention. The paper has already generated more than 100 reprint requests prior to publication. The link to the paper will not be active until publication, but will be:

Fossel M. A Unified Model of Dementias and Age-Related Neurodegeneration. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. January 2020. https://doi.org/10.1002/alz.12012

The paper is long (17k words, 269 references) even before the editors requested that I write an appendix, describing the dialogue with the reviewers. If you’d like a copy, please ask.

I hope you find the article intriguing. 

6 Comments »

  1. Please forward a pdf of your article
    A Unified Model of Dementias and Age-Related Neurodegeneration.
    Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. January 2020.

    The doi did not work.

    Thank you for this courtesy,

    Ed

    Comment by Edward Blonz — January 8, 2020 @ 10:57 am

  2. As stated, the DOI wouldn’t work prior to publication.
    It became effective on 1/14/20.

    Comment by admin — February 3, 2020 @ 11:57 am

  3. Congratulations Dr Fossel, this seems amazingly positive!

    You’ve been busy, it seems. I’m assuming the novel point of intervention will be telomerase induction, but am eager to learn more.

    I would love a copy, please.

    Oliver Ward

    Comment by Oliver Ward — January 12, 2020 @ 6:57 pm

  4. Oliver: You can probably get it online, but feel free to email me at michael.fossel@telocyte.com and I can send a copy.

    Comment by admin — February 3, 2020 @ 11:58 am

  5. Congratulations!

    Truly monumental task! Perhaps not as arduous as defeating Alzheimer will prove to be!

    One would hope.

    Comment by Alex Dumitru — January 30, 2020 @ 7:54 pm

  6. Keep going Michael, I believe you are on the right track. I am hoping the AD Human Trial goes as expected with significant disease reversal. And you are spot on, Compassion is the reason to persist.
    Kind Regards,
    Stephen Rodwell (BSc, GradDipCompSci)

    Comment by Stephen Rodwell — February 18, 2020 @ 1:34 am

RSS feed for comments on this post.

Leave a comment

Powered by WordPress